Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases

US7388002B2 · kind B2 · utility

Assignee

• BioCryst Pharmaceuticals, Inc. · US

Inventors

• Yarlagadda S. Babu · Birmingham, US
• Pooran Chand · Birmingham, US
• Yahya El-Kattan · Hoover, US
• Minwan Wu · Vestavia Hills, US

Key dates

• Filing date: Nov 9, 2005
• Grant date: Jun 17, 2008
• Expiry date: Dec 26, 2025

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds represented by the formula: Both R3 and R4 can form a monocyclic ring of 4-7 atoms with N or optionally a further heteroatom in the ring;